1. 101 Oncological outcomes following risk reducing bilateral salpingo-oophorectomy in women deemed high risk for ovarian cancer. (13th November 2020) Authors: Smallwood, K; Huang, V; Phillips, A; Crockett, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 375 The changing nature of referral pathways for risk reducing salpingo-oophorectomy in a UK cancer centre. (13th November 2020) Authors: Smallwood, K; Phillips, A; Asher, V; Crockett, S; Huang, V Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 998TiPPamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China. (23rd October 2018) Authors: Wu, X; Wang, J; Zhou, Q; Gu, T; Zhang, K; Liang, J; Mu, S; Ge, R; Yang, H; Huang, V; Brachmann, R; Wang, L; Li, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A102 THIOPURINE METABOLITE LEVEL MONITORING LEADS TO INDIVIDUALIZED AND OPTIMIZED THIOPURINE THERAPY IN ADULT INFLAMMATORY BOWEL DISEASE (IBD). (1st March 2018) Authors: Zhu, J; Abraldes, J; Dieleman, L A; Huang, V; Kroeker, K I; Peerani, F; Wong, K; LeGatt, D; Fedorak, R; Halloran, B P Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A105 AN ONLINE EDUCATIONAL PORTAL IMPROVES CONCERNS OF INFLAMMATORY BOWEL DISEASE PATIENTS REGARDING PREGNANCY AND MEDICATION. (1st March 2018) Authors: Sutton, R T; Wierstra, K; Ambrosio, L; Dieleman, L A; Halloran, B P; Kroeker, K I; Fedorak, R; Wong, K; Berga, K; Huang, V Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A108 USTEKINUMAB IS EFFECTIVE FOR INDUCING CLINICAL, ENDOSCOPIC, AND RADIOGRAPHIC RESPONSE IN REFRACTORY MODERATE-TO-SEVERE CROHN'S DISEASE: A MULTICENTRE COHORT STUDY. (1st March 2018) Authors: Ma, C; Fedorak, R; Kaplan, G G; Dieleman, L A; Devlin, S; Stern, N; Kroeker, K I; Seow, C; Leung, Y; Novak, K L; Halloran, B P; Huang, V; Wong, K; Ghosh, S; Panaccione, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A131 ELECTRONIC HEALTH RECORD–BASED SMARTSETS INTEGRATE VARIOUS ASPECTS OF FLARE MANAGEMENT IN OUTPATIENTS WITH INFLAMMATORY BOWEL DISEASE THEREFORE ENSURING CONTINUITY OF CARE. (1st March 2018) Authors: Lytvyak, E; Devlin, S; Dieleman, L A; Halloran, B P; Huang, V; Kroeker, K I; Panaccione, R; Peerani, F; Wong, K; Fedorak, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN. (1st March 2018) Authors: Stern, N; Wong, K; Dieleman, L A; Halloran, B P; Huang, V; Kroeker, K I; Peerani, F; van Zanten, S; Fedorak, R Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A137 THERAPEUTIC DRUG MONITORING WITH INFLIXIMAB TROUGH LEVELS LEAD TO INCREASED INTERVENTION. (1st March 2018) Authors: Stern, N C; Fedorak, R; Wong, K; Halloran, B P; Dieleman, L A; Huang, V; Peerani, F; Kroeker, K I Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A139 AGREEMENT OF IBDOC® AND QUANTON CAL® RAPID LATERAL FLOW-BASED FECAL CALPROTECTIN TESTS WITH ACCEPTED LAB-BASED ASSAYS FOR MONITORING INFLAMMATORY BOWEL DISEASE. (1st March 2018) Authors: Sutton, R T; Prosser, C; Dhami, N; Sadowski, D; van Zanten, S; Kroeker, K I; Wong, K; Halloran, B P; Fedorak, R; Huang, V Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗